MS
MatsukiyoCocokara & Co.
MSMKF · OTC
$14.88 +0.00% (+$0.00)
Market Cap ¥918.9B
P/E Ratio 15.87x
Div. Yield 2.19%
ROE 10.82%
Bulios Fair Price
$16.21
8.9% upside
Current Price
$14.88
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MSMKF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
78 /100
Cheap PEG 6.16x
P/S 0.81x
P/B 1.72x
Growth
58 /100
Stable Rev. growth 5.73%
FCF growth 8.42%
Book val. growth 4.27%
Profitability
32 /100
Weak Net margin 5.09%
Op. margin 7.71%
FCF margin 0.00%
Quality
63 /100
Average ROE 10.82%
ROA 7.91%
Asset turnover 1.55x
Debt
100 /100
Low Current ratio 2.29x
Int. coverage 1,698.66x
Net debt/EBITDA -0.75x
Stability
88 /100
Stable Rev. volatility 1.84%
EPS volatility 14.20%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MSMKF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Kiyoo Matsumoto
Employees
14,293
Headquarters
Tokyo
Upcoming events
29 SEP
Ex-Dividend
Ex-dividend date
29 SEP
Dividend Payment
Payment date
16 NOV
Earnings
Upcoming earnings report
30 MAR
Ex-Dividend
Ex-dividend date
30 MAR
Dividend Payment
Payment date